홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Methanol → 4-[[N-(2-amino-4,5-difluorobenzoyl)glycyl]aminomethyl]-1-(benzo[c]furazan-5-yl)piperidine

HRID 133617
인쇄

반응식

HRID 133617 반응식
C(OC([NH:8][C:9]1[CH:28]=[C:27]([F:29])[C:26]([F:30])=[CH:25][C:10]=1[C:11]([NH:13][CH2:14][C:15]([NH:17][CH2:18][CH:19]1[CH2:24][CH2:23][NH:22][CH2:21][CH2:20]1)=[O:16])=[O:12])=O)(C)(C)C.BrC[C:33]1[CH:41]=[CH:40][C:36]2=[N:37][O:38][N:39]=[C:35]2[CH:34]=1.C1CCNCC1.CO>C(Cl)(Cl)Cl.C(#N)C>[NH2:8][C:9]1[CH:28]=[C:27]([F:29])[C:26]([F:30])=[CH:25][C:10]=1[C:11]([NH:13][CH2:14][C:15]([NH:17][CH2:18][CH:19]1[CH2:20][CH2:21][N:22]([C:33]2[CH:41]=[CH:40][C:36]3=[N:37][O:38][N:39]=[C:35]3[CH:34]=2)[CH2:23][CH2:24]1)=[O:16])=[O:12]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 887MethanolHCID 8082PiperidineHCID 27355875-(Bromomethyl)-2,1,3-benzoxadiazoleHCID 184262024-[[N-(2-(tert-butoxycarbonylamino)-4,5-difluorobenzoyl)glycyl]aminomethyl]piperidine

생성물 1

HCID 184262184-[[N-(2-amino-4,5-difluorobenzoyl)glycyl]aminomethyl]-1-(benzo[c]furazan-5-yl)piperidine

시약·촉매·용매 2

HCID 6212
Chloroform
용매
HCID 6342Acetonitrile용매

실험 절차

A mixture of 4-[[N-(2-(tert-butoxycarbonylamino)-4,5-difluorobenzoyl)glycyl]aminomethyl]piperidine (0.050 mmol) with 5-(bromomethyl)benzo[c]furazan (0.75 mL), a (piperidinomethyl)polystyrene (2.6-2.8 mmol/g, 60 mg, 0.15 mmol), methanol (0.2 mL), acetonitrile (1.0 mL) and chloroform (0.50 mL) was stirred at 50° C. overnight, cooled to room temperature, loaded onto a Varian™ SCX column and washed with methanol (5 mL×2). The obtained crude product was eluted with a 2 M methanol solution of NH3 (5 mL) and concentrated. Chloroform (1.5 mL) and phenyl isocyanate (0.075 mL) were added to the residue, and the resulting mixture was stirred at room temperature for 1 hour, loaded onto a Varian™ SCX column and washed with methanol (5 mLX 2). The obtained crude product was eluted with a 2 M methanol solution of NH3 (5 mL) and concentrated. The resulting residue was dissolved in methanol (1 mL), and a 4 M dioxane solution of HCl (0.50 ml) was added to the obtained solution. The resulting mixture was stirred at room temperature overnight and concentrated. The residue was then dissolved in methanol, loaded onto a Varian™ SCX column, washed with methanol (5 mL×2), eluted with a 2 M methanol solution of NH3 (5 mL), concentrated and then purified by preparative TLC (SiO2, ethyl acetate/methanol=5:1) to provide 4-[[N-(2-amino-4,5-difluorobenzoyl)glycyl]aminomethyl]-1-(benzo[c]furazan-5-yl)piperidine (Compd. No. 2130) (3.6 mg, 16%). The purity was determined by RPLC/MS (87%). ESI/MS m/e 459.3 (M++H, C22H24F2N6O3).

후처리

  1. washwashed with methanol (5 mL×2)
  2. customThe obtained crude product
  3. washwas eluted with a 2 M methanol solution of NH3 (5 mL)
  4. concentrationconcentrated
  5. additionChloroform (1.5 mL) and phenyl isocyanate (0.075 mL) were added to the residue
  6. washwashed with methanol (5 mLX 2)
  7. customThe obtained crude product
  8. washwas eluted with a 2 M methanol solution of NH3 (5 mL)
  9. concentrationconcentrated
  10. dissolutionThe resulting residue was dissolved in methanol (1 mL)
  11. additiona 4 M dioxane solution of HCl (0.50 ml) was added to the obtained solution
  12. stirringThe resulting mixture was stirred at room temperature overnight
  13. concentrationconcentrated
  14. dissolutionThe residue was then dissolved in methanol
  15. washwashed with methanol (5 mL×2)
  16. washeluted with a 2 M methanol solution of NH3 (5 mL)
  17. concentrationconcentrated
  18. custompurified by preparative TLC (SiO2, ethyl acetate/methanol=5:1)

출처 및 근거

ORD 기록
ord-5b3302665e2c4ebfba48b670de53180f
출처 데이터셋
uspto-grants-2008_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07390830B1

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트